netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
  • CONTACT US
No announcement available or all announcement expired.
netscientific
netscientific
  • ABOUT US
  • TEAM
    • CAREERS
  • PORTFOLIO
  • INVESTORS
    • RNS & RNS REACH
    • FINANCIAL RESULTS
    • CORPORATE GOVERNANCE
  • NEWS
  • CONTACT US

Grant of Options to Directors

Jun 26, 2018
-
RNS Announcements

London, UK – 26th June 2018 – NetScientific plc (AIM:NSCI) (the “Company”), the transatlantic healthcare IP commercialisation Group, today announced that on 21st June 2018, options over ordinary shares of 5p each were granted to its CEO François Martelet and CFO Ian Postlethwaite as detailed below (the “New Options”).

 

Director Number of Options Granted Total Number of Options Held
Francois Martelet 300,000 1,059,020
Ian Postlethwaite 200,000 560,000

 

The New Options have an exercise price of 45.5 pence per share, being the average closing price for the ordinary shares over the five dealing days prior to the date on which the options were granted. The New Options vest three years from the date of grant.

 

For more information, please contact:

 

  NetScientific

François R. Martelet, M.D., CEO

Ian Postlethwaite, CFO

Tel: +44 (0)20 3514 1800
 Consilium Strategic Communications

Mary-Jane Elliott Jessica Hodgson /

Chris Welsh / Laura Thornton

Tel: +44 (0)20 3709 5700

netscientific@consilium-comms.com

Stifel Nicolaus Europe Limited (NOMAD and Broker)

Jonathan Senior / David Arch / Ben Maddison

 

 Tel: +44 (0) 20 7710 7600

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail on the grant of options to PDMRs.

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name  Francois Martelet
2 Reason for the notification
a) Position/status  CEO, NetScientific plc
b) Initial notification/ Amendment  Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name NetScientific plc
b) LEI 213800N5WD46G1Y7I458
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

 

Identification code

Option over Ordinary Shares

 

ISIN for NetScientific plc Ordinary Shares: GB00B9F4MT28

 

b) Nature of the transaction Grant of option
c) Price(s) and volume(s)
Price(s) Volume(s)
 £0.455  300,000

 

d) Aggregated information

–      Aggregated volume

–      Price

 

300,000

£0.455

e) Date of the transaction 21 June 2018
f) Place of the transaction Off market

 

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name  Ian Postlethwaite
2 Reason for the notification
a) Position/status  CFO, NetScientific plc
b) Initial notification/ Amendment  Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name NetScientific plc
b) LEI 213800N5WD46G1Y7I458
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument

 

Identification code

Option over Ordinary Shares

 

ISIN for NetScientific plc Ordinary Shares: GB00B9F4MT28

 

b) Nature of the transaction Grant of option
c) Price(s) and volume(s)
Price(s) Volume(s)
 £0.455  200,000

 

d) Aggregated information

–      Aggregated volume

–      Price

 

200,000

£0.455

e) Date of the transaction 21 June 2018
f) Place of the transaction Off market

 

 

About NetScientific

 

NetScientific is a transatlantic healthcare technology group with an investment strategy focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases. For more information, please visit the website at www.netscientific.net

 

Share on FacebookShare on TwitterShare on Linkedin
← PREVIOUS POST
Portfolio Company, Wanda Enhances Remote Patient Monitoring Platform with Improved Patient Adherence Features
NEXT POST →
Result of AGM

 

NetScientific plc

Level 39,
One Canada Square,
London, E14 5AB

Tel: +44 20 3514 1800
www.netscientific.net
info@netscientific.net

  • RNS & RNS Reach
  • Financial Results
  • Financial Calendar
  • Corporate Governance
  • News
  • Historic Material
copyright
Terms of Use
Grant of Options to Directors - NetScientific
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.